BIOMAT Database Logo BIOMAT Database Logo

Cerebrospinal fluid changes in HIV-1 infection. 1988

M Andersson, and T Bergström, and C Blomstrand, and S Hermodsson, and C Håkansson, and G B Löwhagen
Department of Neurology, University of Gothenburg, Sahlgren's Hospital, Sweden.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D002555 Cerebrospinal Fluid A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES. Cerebro Spinal Fluid,Cerebro Spinal Fluids,Cerebrospinal Fluids,Fluid, Cerebro Spinal,Fluid, Cerebrospinal,Fluids, Cerebro Spinal,Fluids, Cerebrospinal,Spinal Fluid, Cerebro,Spinal Fluids, Cerebro
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated

Related Publications

M Andersson, and T Bergström, and C Blomstrand, and S Hermodsson, and C Håkansson, and G B Löwhagen
Cerebrospinal fluid dopamine in HIV-1 infection.
January 1994, AIDS (London, England),
M Andersson, and T Bergström, and C Blomstrand, and S Hermodsson, and C Håkansson, and G B Löwhagen
Raltegravir cerebrospinal fluid concentrations in HIV-1 infection.
September 2009, PloS one,
M Andersson, and T Bergström, and C Blomstrand, and S Hermodsson, and C Håkansson, and G B Löwhagen
[Changes in the cerebrospinal fluid in patients with HIV infection].
February 1990, Revista clinica espanola,
M Andersson, and T Bergström, and C Blomstrand, and S Hermodsson, and C Håkansson, and G B Löwhagen
Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection.
August 1999, Journal of acquired immune deficiency syndromes (1999),
M Andersson, and T Bergström, and C Blomstrand, and S Hermodsson, and C Håkansson, and G B Löwhagen
Cerebrospinal fluid anti-cardiolipin antibodies in patients with HIV-1 infection.
January 1991, Journal of acquired immune deficiency syndromes,
M Andersson, and T Bergström, and C Blomstrand, and S Hermodsson, and C Håkansson, and G B Löwhagen
Changes in Cerebrospinal Fluid Proteins across the Spectrum of Untreated and Treated Chronic HIV-1 Infection.
May 2024, bioRxiv : the preprint server for biology,
M Andersson, and T Bergström, and C Blomstrand, and S Hermodsson, and C Håkansson, and G B Löwhagen
Cytoimmunological abnormalities in cerebrospinal fluid in early stages of HIV-1 infection often precede changes in blood.
May 1993, Journal of neuroimmunology,
M Andersson, and T Bergström, and C Blomstrand, and S Hermodsson, and C Håkansson, and G B Löwhagen
Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment.
January 2005, Antiviral therapy,
M Andersson, and T Bergström, and C Blomstrand, and S Hermodsson, and C Håkansson, and G B Löwhagen
Cerebrospinal fluid antibodies directed against neuron-associated gangliosides in HIV-1 infection.
January 2000, Infection,
M Andersson, and T Bergström, and C Blomstrand, and S Hermodsson, and C Håkansson, and G B Löwhagen
Cerebrospinal fluid 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in HIV-1 infection.
January 2001, Neuropsychobiology,
Copied contents to your clipboard!